1074 related articles for article (PubMed ID: 20560457)
1. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
3. [Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].
Takizawa H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():694-6. PubMed ID: 20942166
[No Abstract] [Full Text] [Related]
4. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
5. [Antineutrophil cytoplasmic antibody(ANCA)].
Yoshida M
Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
7. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
8. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
Reynolds WF; Stegeman CA; Tervaert JW
Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
[TBL] [Abstract][Full Text] [Related]
9. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of pulmonary vasculitis.
Yunt ZX; Frankel SK; Brown KK
Ther Adv Respir Dis; 2012 Dec; 6(6):375-90. PubMed ID: 22878624
[TBL] [Abstract][Full Text] [Related]
12. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
15. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
[TBL] [Abstract][Full Text] [Related]
17. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
Zhang X; Jiang M; Chui J; Wang H; Ma J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
[TBL] [Abstract][Full Text] [Related]
18. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
20. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
